Manuel Martínez‐Bueno

3.5k citations
15 papers · 1.2k indexed · 1 hit paper · h-index 12

Manuel Martínez‐Bueno

15 papers receiving 1.2k citations

Hit Papers

The TetR Family of Transcriptional Repressors8842005202620122019250500750

Peers

Manuel Martínez‐Bueno
Comparison fields: 5 of 96
  • Molecular Medicine 153
  • Endocrinology 91
  • Genetics 342
  • Molecular Biology 768
  • Pharmacology 176
Replace Yaomei Tian with:
Yaomei Tian China
Edward DeMoll United States
Christine Jacobs United States
Shuqiang Huang China
Hanjing Yang United States
Stefan Homburg Germany
Alessandra M. Albertini Italy
Maren Scharfe Germany
Kuanqing Liu United States
Josette Pidoux France
Manuel Martínez‐Bueno relative to Yaomei Tian China Yaomei Tian's profile →
Citations per field
00.5×3.5×
Yaomei Tian · 1×
Citations per year

Countries citing papers authored by Manuel Martínez‐Bueno

Since Specialization
Citations

This map shows the geographic impact of Manuel Martínez‐Bueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Martínez‐Bueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Martínez‐Bueno more than expected).

Fields of papers citing papers by Manuel Martínez‐Bueno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Martínez‐Bueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Martínez‐Bueno. The network helps show where Manuel Martínez‐Bueno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuel Martínez‐Bueno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Martínez‐Bueno Line = papers co-authored together Manuel Martínez‐Bueno links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20243
2 202223
3 20229
4 202228
5 201914
6 201925
7 201921
8 201812
9 201824
10 20163
11 201430
12 200732
13
The TetR Family of Transcriptional Repressorsbreakdown →
2005884
14 200428
15 200273

About Manuel Martínez‐Bueno

Manuel Martínez‐Bueno is a scholar working on Rheumatology, Genetics and Immunology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Bacterial Genetics and Biotechnology (4 papers), Genetic Associations and Epidemiology (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Epigenetics and DNA Methylation (2 papers), Genomics and Phylogenetic Studies (2 papers), Inflammasome and immune disorders (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Medicine (153 citations), Endocrinology (91 citations) and Genetics (342 citations). Manuel Martínez‐Bueno has collaborated with scholars based in Spain, Sweden and United States. Frequent co-authors include Juan L. Ramos, Raquel Tobes, Antonio J. Molina‐Henares, María‐Trinidad Gallegos, Wilson Terán, Xiaodong Zhang, Kazuya Watanabe, Richard G. Brennan, Marta E. Alarcón‐Riquelme and Manuel Rey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026